ALKEM / NSE / Biotechnology & Drugs
Alkem Laboratories
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High5,933
Target Low4,716.75
Target Mean2.5
Target Median87.5
Risk Metrics
Overall RiskBalanced risk
Board Risk26.07
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Alkem Laboratories to host analyst meet on June 19, 2026 scanx.trade
NCLT Mumbai Allows First Motion in Alkem–Adroit Biomed Merger, Orders Shareholders' Meeting LiveLawBiz
Alkem Laboratories Ltd Stock (INE540L01014): Analyst call and valuation shifts put pharma name in fo AD HOC NEWS
Alkem Labs Schedules One-on-One Analyst Meet in Mumbai The Globe and Mail
Add Alkem Laboratories Ltd for the Target Rs. 5,755 by Choice Institutional Equities Investment Guru
Bombay High Court Restrains ACIPROX Trademark: Landmark Pharmaceutical Trademark Infringement Judgment in Alkem Laboratories v. Numen Pharma (2026) Legal Service India
Alkem Laboratories to meet Haitong Securities on June 16 scanx.trade
Alkem Laboratories Ltd stock (INE540L01014): earnings momentum in India’s pharma market AD HOC NEWS
© SharekeyX | Rusaka Technologies 2024-2026

